Theradaptive
PrivateLast Round
Grant
May 22, 2024
Total Funding Raised
$44.6M
Momentum Score
25 /100
Company Overview
Theradaptive is a biotechnology company that offers a drug delivery and research platform aimed at transforming therapeutic delivery through the creation of material-binding variants of recombinant proteins for use in implants, devices, and injectable carriers in various medical applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Defense Tech, Advanced Materials
Business Model
B2G
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Theradaptive Comps
Public and private peers based on sector, stage, and business model.
Theradaptive Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 22, 2024 | ||||
| Grant | Sep 26, 2023 | ||||
| Grant | Jul 6, 2023 | ||||
| Series A | Jun 15, 2023 | ||||
| Grant | Mar 1, 2023 | ||||
Seed | Jan 9, 2021 |
Key People
Founding team and executive leadership
Theradaptive Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maryland Stem Cell Research Fund | Grant |
| Maryland Venture Fund | Seed |
Theradaptive Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Theradaptive's valuation, stock price, and market status.
